Skip to main content
Top
Published in: Comparative Hepatology 1/2004

Open Access 01-01-2004 | Proceedings

Use of Flow Cytometric Analysis to Examine the Uptake of Apoptotic Bodies by Healthy Hepatocytes

Authors: Carol A Casey, Cheryl R Baldwin, Jacy L Kubik, Agnes M Hindemith, Benita L McVicker

Published in: Comparative Hepatology | Special Issue 1/2004

Login to get access

Excerpt

The spectrum of liver disease after alcohol abuse is similar to many other types of liver diseases in that damage to the hepatocyte, or parenchymal cell, is the cardinal event in the pathogenesis of injury. Damage to the liver, however, involves not only the hepatocyte but also the nonparenchymal cells: the Kupffer, endothelial, and stellate cells which release inflammatory and fibrogenic factors (such as cytokines and chemokines) that lead to altered liver pathology. We have studied extensively the effects of ethanol administration on protein trafficking in the liver, focusing most of our work on the hepatocyte and the process of endocytosis by these cells, using the endocytic pathway of the asialoglycoprotein receptor (ASGP-R) as a model [18]. Currently in our laboratory we are examining the effect of ethanol administration on the process of apoptosis (programmed cell death) to determine a role for altered endocytosis in this process. Apoptosis is recognized not only as one of the initiating events in toxic liver injury, but is also increasingly recognized as a key mechanism in tissue inflammation and fibrosis [9, 10]. Of interest to us is work showing that healthy hepatocytes can bind and internalize apoptotic bodies [11, 12], and that the hepatocellular ASGP-R is involved in this clearance. We have utilized an in vitro system to characterize uptake of apoptotic bodies in isolated hepatocytes and define a role for the ASGP-R in this uptake. Our goal is to determine if there is an impaired ability to take up bodies in hepatocytes from ethanol-fed animals compared with control hepatocytes. An ethanol-induced impairment in the ability to remove apoptotic cells in the liver parenchyma could lead to an accumulation of bodies thereby disturbing the hepatic architecture and contributing to the initiation of fibrosis, specifically by activation of the non-parenchymal cell population. The work described in this present study was performed to characterize the in vitro system using flow cytometry to examine uptake of apoptotic bodies by healthy hepatocytes. Our long-term goal is to determine whether inadequate removal of apoptotic cells, presumably via altered receptor-mediated endocytosis (RME), plays a role in the course of pathogenesis of alcoholic liver injury. …
Literature
1.
go back to reference Casey CA, Kragskow SL, Sorrell MF, Tuma DJ: Chronic ethanol administration impairs the binding and endocytosis of asialo-orosomucoid in isolated rat hepatocytes. J Biol Chem. 1987, 262: 2704-2710.PubMed Casey CA, Kragskow SL, Sorrell MF, Tuma DJ: Chronic ethanol administration impairs the binding and endocytosis of asialo-orosomucoid in isolated rat hepatocytes. J Biol Chem. 1987, 262: 2704-2710.PubMed
2.
go back to reference Casey CA, Kragskow SL, Sorrell MF, Tuma DJ: Effects of chronic ethanol administration on total asialoglycoprotein receptor content and intracellular processing of asialoorosomucoid in isolated rat hepatocytes. Biochim Biophys Acta. 1990, 1052: 1-8. 10.1016/0167-4889(90)90049-J.CrossRefPubMed Casey CA, Kragskow SL, Sorrell MF, Tuma DJ: Effects of chronic ethanol administration on total asialoglycoprotein receptor content and intracellular processing of asialoorosomucoid in isolated rat hepatocytes. Biochim Biophys Acta. 1990, 1052: 1-8. 10.1016/0167-4889(90)90049-J.CrossRefPubMed
3.
go back to reference Casey CA, Kragskow SL, Sorrell MF, Tuma DJ: Ethanol-induced impairments in receptor-mediated endocytosis of asialoorosomucoid in isolated rat hepatocytes: Time course of impairments and recovery after ethanol withdrawal. Alcohol Clin Exp Res. 1989, 13: 258-263. 10.1111/j.1530-0277.1989.tb00323.x.CrossRefPubMed Casey CA, Kragskow SL, Sorrell MF, Tuma DJ: Ethanol-induced impairments in receptor-mediated endocytosis of asialoorosomucoid in isolated rat hepatocytes: Time course of impairments and recovery after ethanol withdrawal. Alcohol Clin Exp Res. 1989, 13: 258-263. 10.1111/j.1530-0277.1989.tb00323.x.CrossRefPubMed
4.
go back to reference Casey CA, Kragskow SL, Sorrell MF, Tuma DJ: Zonal differences in ethanol-induced impairments in receptor-mediated endocytosis (RME) of asialoorosomucoid (ASOR) in isolated rat hepatocytes. Hepatology. 1991, 13: 260-266. 10.1016/0270-9139(91)92438-E.PubMed Casey CA, Kragskow SL, Sorrell MF, Tuma DJ: Zonal differences in ethanol-induced impairments in receptor-mediated endocytosis (RME) of asialoorosomucoid (ASOR) in isolated rat hepatocytes. Hepatology. 1991, 13: 260-266. 10.1016/0270-9139(91)92438-E.PubMed
5.
go back to reference Casey CA, Wiegert RL, Tuma DJ: Effect of hyperosmolarity on both receptor-mediated and fluid-phase endocytosis in ethanol-fed animals. Biochem Pharm. 1995, 49: 1117-1123. 10.1016/0006-2952(95)98509-8.CrossRefPubMed Casey CA, Wiegert RL, Tuma DJ: Effect of hyperosmolarity on both receptor-mediated and fluid-phase endocytosis in ethanol-fed animals. Biochem Pharm. 1995, 49: 1117-1123. 10.1016/0006-2952(95)98509-8.CrossRefPubMed
6.
go back to reference McVicker BL, Casey CA: Effects of ethanol on receptor-mediated endocytosis in the liver. ALCOHOL. 1999, 19: 255-260. 10.1016/S0741-8329(99)00043-9.CrossRefPubMed McVicker BL, Casey CA: Effects of ethanol on receptor-mediated endocytosis in the liver. ALCOHOL. 1999, 19: 255-260. 10.1016/S0741-8329(99)00043-9.CrossRefPubMed
7.
go back to reference McVicker BL, Tuma DJ, Casey CA: Ethanol administration results in hyperphosphorylation of the asialoglycoprotein receptor in isolated rat hepatocytes. Biochemical Pharmacology. 2000, 60: 343-351. 10.1016/S0006-2952(00)00353-1.CrossRefPubMed McVicker BL, Tuma DJ, Casey CA: Ethanol administration results in hyperphosphorylation of the asialoglycoprotein receptor in isolated rat hepatocytes. Biochemical Pharmacology. 2000, 60: 343-351. 10.1016/S0006-2952(00)00353-1.CrossRefPubMed
8.
go back to reference Tworek BL, Tuma DJ, Casey CA: Decreased binding of asialoglycoproteins to hepatocytes from ethanol rats: consequence of both impaired receptor synthesis and inactivation of the asialoglycoprotein receptor. J Biol Chem. 1996, 271: 2531-2538. 10.1074/jbc.271.5.2531.CrossRefPubMed Tworek BL, Tuma DJ, Casey CA: Decreased binding of asialoglycoproteins to hepatocytes from ethanol rats: consequence of both impaired receptor synthesis and inactivation of the asialoglycoprotein receptor. J Biol Chem. 1996, 271: 2531-2538. 10.1074/jbc.271.5.2531.CrossRefPubMed
9.
go back to reference Yacoub LK, Fogt F, Griniuviene B, Nanji AA: Apoptosis and bcl2 protein expression in experimental alcoholic liver disease in the rat. Alcohol Clin Exp Res. 1995, 19: 854-859. 10.1111/j.1530-0277.1995.tb00958.x.CrossRefPubMed Yacoub LK, Fogt F, Griniuviene B, Nanji AA: Apoptosis and bcl2 protein expression in experimental alcoholic liver disease in the rat. Alcohol Clin Exp Res. 1995, 19: 854-859. 10.1111/j.1530-0277.1995.tb00958.x.CrossRefPubMed
10.
go back to reference Kawahara H, Matsuda Y, Takase S: Is apoptosis involved in alcoholic hepatitis?. Alcohol Alcohol. 1994, 29: 113-119. Kawahara H, Matsuda Y, Takase S: Is apoptosis involved in alcoholic hepatitis?. Alcohol Alcohol. 1994, 29: 113-119.
11.
go back to reference Dini L, Autuori F, Lentini A, Oliverio S, Piacentini M: The clearance of apoptotic cells in the liver is mediated by the asialoglycoprotein receptor. FEBS Lett. 1992, 296: 174-178. 10.1016/0014-5793(92)80373-O.CrossRefPubMed Dini L, Autuori F, Lentini A, Oliverio S, Piacentini M: The clearance of apoptotic cells in the liver is mediated by the asialoglycoprotein receptor. FEBS Lett. 1992, 296: 174-178. 10.1016/0014-5793(92)80373-O.CrossRefPubMed
12.
go back to reference Dini L, Lentini A, Diez GD, Rocha M, Falasca L, Serafino L, Vidal-Vanaclocha F: Phagocytosis of apoptotic bodies by liver endothelial cells. J Cell Sci. 1995, 108: 967-973.PubMed Dini L, Lentini A, Diez GD, Rocha M, Falasca L, Serafino L, Vidal-Vanaclocha F: Phagocytosis of apoptotic bodies by liver endothelial cells. J Cell Sci. 1995, 108: 967-973.PubMed
Metadata
Title
Use of Flow Cytometric Analysis to Examine the Uptake of Apoptotic Bodies by Healthy Hepatocytes
Authors
Carol A Casey
Cheryl R Baldwin
Jacy L Kubik
Agnes M Hindemith
Benita L McVicker
Publication date
01-01-2004
Publisher
BioMed Central
Published in
Comparative Hepatology / Issue Special Issue 1/2004
Electronic ISSN: 1476-5926
DOI
https://doi.org/10.1186/1476-5926-2-S1-S40

Other articles of this Special Issue 1/2004

Comparative Hepatology 1/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine